Perioperative use of disease‐modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Perioperative Use of Disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Inflammatory Arthritis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431857/all/Perioperative_use_of_disease‐modifying_anti‐rheumatic_drugs__DMARDs__in_people_with_inflammatory_arthritis.
Perioperative use of disease‐modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431857/all/Perioperative_use_of_disease‐modifying_anti‐rheumatic_drugs__DMARDs__in_people_with_inflammatory_arthritis. Accessed August 10, 2026.
Perioperative use of disease‐modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431857/all/Perioperative_use_of_disease‐modifying_anti‐rheumatic_drugs__DMARDs__in_people_with_inflammatory_arthritis
Perioperative Use of Disease‐modifying Anti‐rheumatic Drugs (DMARDs) in People With Inflammatory Arthritis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 August 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431857/all/Perioperative_use_of_disease‐modifying_anti‐rheumatic_drugs__DMARDs__in_people_with_inflammatory_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Perioperative use of disease‐modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis
ID - 431857
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431857/all/Perioperative_use_of_disease‐modifying_anti‐rheumatic_drugs__DMARDs__in_people_with_inflammatory_arthritis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

